Showing results (1021-1030 of 1,084) with videos related to

Sort By:
Pageof 109
JACC. Cardiooncology|January 13, 2023
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After ImmunotherapyCharlotte Lee, Zsofia D Drobni, Amna Zafar, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
Pseudoexfoliation and Cataract Syndrome Associated with Genetic and Epidemiological Factors in a Mayan Cohort of GuatemalaPatrice M Hicks, Elizabeth Au, William Self, et al.
Cancer Research Communications|January 30, 2026
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint InhibitorsNussara Pakvisal, Leontios Pappas, Bennett A Caughey, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
Circulation|May 27, 2018
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial FibrillationChunxia Yao, Tina Veleva, Larry Scott, et al.
Expert Opinion on Drug Safety|April 17, 2026
Refractory immune-related adverse events (irAes) associated with immune checkpoint inhibitor therapy: a multiorgan management reviewMaria Julia Moura, Anirudha Chatterjee, Sharada Wali, et al.
Journal of the American Society of Nephrology : JASN|January 8, 2017
Inhibition of <i>α</i>v<i>β</i>5 Integrin Attenuates Vascular Permeability and Protects against Renal Ischemia-Reperfusion InjuryAmy McCurley, Stella Alimperti, Silvia B Campos-Bilderback, et al.
Cardiovascular Research|April 22, 2026
Inhibition of the PD-1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischemiaTamás G Gergely, Zsófia D Drobni, Tamás Kovács, et al.
Pageof 109